Moreover, reduced NRGN expression was shown to be associated with the degree of Aβ and tau pathology [24]; although other authors found no differences in the levels of NRGN in Brodmann brain areas BA22 (in the superior temporal gyrus) and BA6 (in the frontal cortex) between AD and controls [25]. Here, MAPT is linked to Alzheimer disease.